UNSPSC 51283916: Sulfamazone

This classification denotes a sulfonamide anti-infective agent with the molecular formula C23H24N6O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D7B8U8VA9J, chemically known as alpha-(4-((6-methoxy-3-pyridazinyl)sulfamoyl)anilino)-2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-methanesulfonsaeure but generally known as sulfamazone, which bears US NIH Compound Identifier 187764. European Medicines Agency schedules Sulfamazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10707MIG.

UNSPSC 51283916 Sulfamazone is a Commodity code, but state and local procurement activity under it shows little alignment with the nominal taxonomy entry. Recent opportunities tagged to this code involve naloxone procurement, medical and first aid supplies for emergency response, and pharmaceutical program development — none of which concern sulfamazone, a sulfonamide antibiotic. The mismatch suggests either data-coding error in the source records or that sulfamazone itself represents a narrow slice of a much broader pharmaceutical and medical-supply purchasing pattern. Where actual buying does occur under pharmaceutical commodity codes at the state and local level, issuing bodies include county health departments (Seminole County, Florida), city fire and emergency services (Tampa Fire Department), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances spanning multiple states and jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participants). These entities buy generic pharmaceuticals, naloxone, emergency medical supplies, and OTC products through both direct procurement and cooperative agreements.

Recent activity concentrates in Florida and Minnesota, with secondary activity in Texas. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2026 — though the source contains a date inconsistency) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to Sanford, Florida. The City of Tampa issued an ITB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for its Fire Department Rescue Division, estimated at $700,000.00 and designated as sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement issued an RFP through MMCAP (S1070000015802, proposals due March 26, 2026) to establish multiple-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers, serving Minnesota and Oregon with contract start July 1, 2026. The Texas HHS Commission issued a Request for Information (RFI HHS0017013, responses due April 3, 2026) to gather vendor intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements — an exploratory procurement preceding formal solicitation.